Boehringer Ingelheim’s blockbuster diabetes drug goes off patent today—Will it lower treatment costs in India? Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure. By Sushmita PandaMarch 11, 2025 10:51 IST
India diabetes care devices market to record CAGR of around 4 percent through 2033: GlobalData GlobalData’s research reveals that India accounted for around 20% of the Asia-Pacific (APAC) diabetes care devices market in 2024 By Health DeskMarch 10, 2025 15:53 IST
Sun Pharma to acquire Checkpoint Therapeutics to strengthen global onco-derma franchise For the nine-month period ending September 2024, Checkpoint reported $0.04 million in revenue and a net loss of $27.3 million. By Sushmita PandaMarch 10, 2025 10:43 IST
Pharma exporters eye ‘preferential treatment’ by US India currently exports about $8.7 billion worth of formulations (generic drugs) and $1 billion of API (active pharmaceutical ingredients) annually… By Manu KaushikMarch 7, 2025 21:08 IST
Biocon Biologics partners with Civica to expand Insulin Aspart access in United States Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical trials. By Health DeskMarch 6, 2025 18:12 IST
Novo Nordisk to launch new therapies in blood and growth disorders after success in diabetes and obesity Martin Holst Lange, Executive Vice President, Development, Novo Nordisk, highlighted during the press briefing that their purpose is to address… By Sushmita PandaMarch 6, 2025 17:46 IST
Novo Nordisk CEO warns of drug shortages and price hikes in US Trump’s tariff threat: Experts have warned that additional levies will only serve to push up prices in the already costly… By Sushmita PandaMarch 6, 2025 16:31 IST
Eris Lifesciences appoints Murari Ranganathan as president of Cardiometabolic Business Prior to joining Eris, Ranganathan was Commercial Director, Women’s Health, Metabolics, and International Business at Abbott India Limited. By Health DeskMarch 6, 2025 12:32 IST
Zydus Lifesciences launches breakthrough drug for transplant patients in India Traditional CMV treatments, such as ganciclovir and valganciclovir, have notable limitations, including toxicity and bone marrow suppression. By Health DeskMarch 5, 2025 15:59 IST
US pharma tariff impact: Who gets hit & why All eyes are now on the appetite of the suppliers (the drug makers from India) and buyers (the major drug… By E Kumar SharmaUpdated: March 5, 2025 14:26 IST
Zydus to develop the world’s first combination vaccine to offer protection against shigellosis and typhoid Typhoid is already a disease of concern globally and various endemic countries already have TCV as part of their national… By Health DeskMarch 4, 2025 13:26 IST
Pfizer may soon move its overseas manufacturing to United States to counter potential tariff hit Bourla’s comments come as drugmakers brace for the possibility of 25% tariff on pharmaceutical imports. By Health DeskMarch 4, 2025 11:58 IST
Philips, Medtronic drive innovation in multi-modality heart imaging Mandeep Singh Kumar, vice-president and managing director of Medtronic India, emphasised the impact of this collaboration. By FE BureauMarch 4, 2025 01:30 IST
Ambition after Agra: Metropolis amped up for more lab acquisitions across North India The idea is to build a string-of-pearls across North. We will keep looking for the right acquisition opportunities in other… By E Kumar SharmaMarch 3, 2025 20:19 IST
Swine Flu spike in India: Delhi leads with over 3000 registered cases While Delhi has recorded 3,141 cases, other states are also recording a surge in the seasonal influenza A (H1N1) virus. By Health DeskMarch 3, 2025 13:14 IST
Trump’s NIH funding cuts and freezes raise concerns over US biotech drug development and innovation A notable NIH reform rolled out by Trump was a $4 billion cut to overhead funding for biomedical research by… By Health DeskMarch 2, 2025 13:39 IST
Glenmark recalls 15 lakh bottles of ADHD medication due to ‘CGMP Deviations’ in United States ADHD is a neurodevelopmental disorder that affects a person’s ability to focus, control impulses, and regulate their activity levels. By Health DeskMarch 2, 2025 12:23 IST
Undeterred by turbulent times, pharma titans exude guts & gumption for growth The future seems inevitably aligned to pursuit of innovation, complex generics, tapping newer opportunities in newer therapies, newer technologies while… By E Kumar SharmaUpdated: March 1, 2025 15:21 IST
Upcoming IPOs Next Week: PhysicsWallah among 3 mainboard issues, 7 listings including Lenskart & Groww – Check full list here
Grammys 2026 nominations full list: Kendrick Lamar dominates with 9 nominations, Lady Gaga close behind with 7 mentions
16 Photos Bengaluru ranks 4th highest in residential property prices worldwide 3 months agoAugust 19, 2025
10 Photos In Photos| Trump, Zelenskyy, Starmer, Macron, Meloni and others gather at White House for Ukraine peace talks 3 months agoAugust 19, 2025
7 Photos Carlos Alcaraz vs Jannik Sinner: From 5-0 lead to retirement announcement – Key highlights from Cincinnati Open 2025 finals 3 months agoAugust 19, 2025
